Cells · 2023 · 14 citations · 45 references
Life SciencesBiochemistryPhysiologyAgingBioenergeticsMetabolismEnergy MetabolismGlycolysis RegulationMetabolic ReprogrammingMetabolic SignalingPhotoreceptor PhysiologyRetinal DegenerationAerobic GlycolysisGlycolysisPhotoreceptor MaintenancePhotoreceptor MetabolismPhotoreceptor MorphologyPhotoreceptor Survival PathwaysRetinal Disease ModelsRod Physiology
HK2 and PKM2 are two main regulators of aerobic glycolysis. Photoreceptors (PRs) use aerobic glycolysis to produce the biomass necessary for the daily renewal of their outer segments. Previous work has shown that HK2 and PKM2 are important for the normal function and long-term survival of PRs but are dispensable for PR maturation, and their individual loss has opposing effects on PR survival during acute nutrient deprivation. We generated double conditional (dcKO) mice lacking HK2 and PKM2 expression in rod PRs. Western blotting, immunofluorescence, optical coherence tomography, and electroretinography were used to characterize the phenotype of dcKO animals. Targeted and stable isotope tracing metabolomics, qRT-PCR, and retinal oxygen consumption were performed. We show that dcKO animals displayed early shortening of PR inner/outer segments, followed by loss of PRs with aging, much more rapidly than either knockout alone without functional loss as measured by ERG. Significant alterations to central glucose metabolism were observed without any apparent changes to mitochondrial function, prior to PR degeneration. Finally, PR survival following experimental retinal detachment was unchanged in dcKO animals as compared to wild-type animals. These data suggest that HK2 and PKM2 have differing roles in promoting PR neuroprotection and identifying them has important implications for developing therapeutic options for combating PR loss during retinal disease.
45
ATP Consumption by Mammalian Rod Photoreceptors in Darkness and in Light
Haruhisa Okawa, Alapakkam P. Sampath, Simon B. Laughlin et al. · Current Biology · 2008 · 429 citations · Full text
Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer
Christopher J. Halbrook, Corbin Pontious, Ilya Kovalenko et al. · Cell Metabolism · 2019 · 415 citations · Full text
Medicine, Oncology, Pharmacology +14